183 related articles for article (PubMed ID: 27184990)
1. Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.
Xu J; Janisse J; Ruterbusch JJ; Ager J; Liu J; Holmes-Rovner M; Schwartz KL
Ann Fam Med; 2016 May; 14(3):208-14. PubMed ID: 27184990
[TBL] [Abstract][Full Text] [Related]
2. Patients' survival expectations before localized prostate cancer treatment by treatment status.
Mohan R; Beydoun H; Barnes-Ely ML; Lee L; Davis JW; Lance R; Schellhammer P
J Am Board Fam Med; 2009; 22(3):247-56. PubMed ID: 19429730
[TBL] [Abstract][Full Text] [Related]
3. Choosing active surveillance versus curative treatment in a population-based survey of men with low-risk prostate cancer.
Xu J; Janisse J; Goodman M
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36696653
[TBL] [Abstract][Full Text] [Related]
4. Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.
Xu J; Janisse J; Ruterbusch J; Ager J; Schwartz KL
J Racial Ethn Health Disparities; 2016 Mar; 3(1):35-45. PubMed ID: 26896103
[TBL] [Abstract][Full Text] [Related]
5. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
6. Patient Knowledge and Qualities of Treatment Decisions for Localized Prostate Cancer.
Daum LM; Reamer EN; Ruterbusch JJ; Liu J; Holmes-Rovner M; Xu J
J Am Board Fam Med; 2017; 30(3):288-297. PubMed ID: 28484061
[TBL] [Abstract][Full Text] [Related]
7. Self-rated health as a tool for estimating health-adjusted life expectancy among patients newly diagnosed with localized prostate cancer: a preliminary study.
Mohan R; Beydoun HA; Beydoun MA; Barnes-Eley M; Davis J; Lance R; Schellhammer P
Qual Life Res; 2011 Jun; 20(5):713-21. PubMed ID: 21132389
[TBL] [Abstract][Full Text] [Related]
8. Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer.
Reamer E; Yang F; Holmes-Rovner M; Liu J; Xu J
Biomed Res Int; 2017; 2017():1467056. PubMed ID: 28785574
[TBL] [Abstract][Full Text] [Related]
9. An analysis of watchful waiting for clinically localized prostate cancer.
Steinberg GD; Bales GT; Brendler CB
J Urol; 1998 May; 159(5):1431-6. PubMed ID: 9554328
[TBL] [Abstract][Full Text] [Related]
10. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract][Full Text] [Related]
11. Is 'watchful waiting' a real choice for men with prostate cancer? A qualitative study.
Chapple A; Ziebland S; Herxheimer A; McPherson A; Shepperd S; Miller R
BJU Int; 2002 Aug; 90(3):257-64. PubMed ID: 12133062
[TBL] [Abstract][Full Text] [Related]
12. Patient perspective on watchful waiting/active surveillance for localized prostate cancer.
Xu J; Neale AV; Dailey RK; Eggly S; Schwartz KL
J Am Board Fam Med; 2012; 25(6):763-70. PubMed ID: 23136314
[TBL] [Abstract][Full Text] [Related]
13. Quality of physician-patient relationships is associated with the influence of physician treatment recommendations among patients with prostate cancer who chose active surveillance.
Orom H; Homish DL; Homish GG; Underwood W
Urol Oncol; 2014 May; 32(4):396-402. PubMed ID: 24332649
[TBL] [Abstract][Full Text] [Related]
14. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
[TBL] [Abstract][Full Text] [Related]
15. Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS).
Xu J; Bock CH; Janisse J; Woo J; Cher ML; Ginsburg K; Yacoub R; Goodman M
Cancer; 2024 May; 130(10):1797-1806. PubMed ID: 38247317
[TBL] [Abstract][Full Text] [Related]
16. Emotional Distress Increases the Likelihood of Undergoing Surgery among Men with Localized Prostate Cancer.
Orom H; Underwood W; Biddle C
J Urol; 2017 Feb; 197(2):350-355. PubMed ID: 27506694
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of using guidelines to choose treatment for prostate cancer.
Mohan R; Beydoun H; Davis J; Lance R; Schellhammer P
Can J Urol; 2010 Feb; 17(1):4975-84. PubMed ID: 20156376
[TBL] [Abstract][Full Text] [Related]
18. Patient expectations of benefit from systemic treatments for metastatic prostate cancer.
Oswald LB; Kasimer R; Rappazzo K; Fought AJ; Penson DF; Morgans AK
Cancer Med; 2020 Feb; 9(3):980-987. PubMed ID: 31840434
[TBL] [Abstract][Full Text] [Related]
19. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study.
Myers RE; Leader AE; Censits JH; Trabulsi EJ; Keith SW; Petrich AM; Quinn AM; Den RB; Hurwitz MD; Lallas CD; Hegarty SE; Dicker AP; Zeigler-Johnson CM; Giri VN; Ayaz H; Gomella LG
J Cancer Educ; 2018 Feb; 33(1):180-185. PubMed ID: 27418065
[TBL] [Abstract][Full Text] [Related]
20. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
